Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

AVEO Pharmaceuticals Revenue 2009-2021 | AVEO

For a detailed definition, formula and example for Revenue, check out our new background page here.
AVEO Pharmaceuticals revenue from 2009 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  
AVEO Pharmaceuticals Annual Revenue
(Millions of US $)
2020 $6
2019 $29
2018 $5
2017 $8
2016 $3
2015 $19
2014 $18
2013 $1
2012 $19
2011 $165
2010 $45
2009 $21
2008 $20
AVEO Pharmaceuticals Quarterly Revenue
(Millions of US $)
2021-03-31 $2
2020-12-31 $1
2020-09-30 $4
2020-06-30 $1
2020-03-31 $1
2019-12-31 $1
2019-09-30 $26
2019-06-30 $1
2019-03-31 $2
2018-12-31 $1
2018-09-30 $2
2018-06-30 $0
2018-03-31 $1
2017-12-31 $0
2017-09-30 $5
2017-06-30 $0
2017-03-31 $3
2016-12-31 $0
2016-09-30 $1
2016-06-30 $0
2016-03-31 $1
2015-12-31 $4
2015-09-30 $15
2015-06-30 $0
2015-03-31 $0
2014-12-31 $0
2014-09-30 $1
2014-06-30 $2
2014-03-31 $15
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $16
2012-09-30 $1
2012-06-30 $2
2012-03-31 $1
2011-12-31 $1
2011-09-30 $4
2011-06-30 $27
2011-03-31 $134
2010-12-31 $12
2010-09-30 $6
2010-06-30 $16
2010-03-31 $11
2009-12-31 $6
2009-09-30 $6
2009-06-30 $5
2009-03-31 $4
2008-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.178B $0.006B
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing and commercializing novel cancer therapeutics. Its product candidates are targeted against important mechanisms known or believed to be involved in cancer. Tivozanib, the Company's lead product candidate, is a highly potent and selective oral inhibitor of the vascular endothelial growth factor, or VEGF, receptors 1, 2 and 3. In addition to tivozanib, AVEO Pharmaceuticals has a pipeline of monoclonal antibodies derived from Human Response Platform (HRP), a novel method of building preclinical models of human cancer, which are intended to more accurately represent cancer biology in patients. AV-299 is the Company's next product candidate which is an antibody that binds to hepatocyte growth factor, or HGF, thereby blocking its function. AVEO Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $150.815B 10.04
Moderna (MRNA) United States $141.980B 282.88
Amgen (AMGN) United States $138.778B 14.98
CSL (CSLLY) Australia $96.851B 0.00
Gilead Sciences (GILD) United States $85.648B 8.28
BioNTech SE (BNTX) Germany $79.303B 57.50
Illumina (ILMN) United States $72.380B 104.37
Regeneron Pharmaceuticals (REGN) United States $61.221B 17.53
Vertex Pharmaceuticals (VRTX) United States $52.182B 20.32
Biogen (BIIB) United States $48.694B 13.37
Genmab (GNMSF) Denmark $29.678B 6.44
Genmab (GMAB) Denmark $29.590B 34.66
BeiGene (BGNE) Cayman Islands $29.247B 0.00
Seagen (SGEN) United States $27.907B 47.05
Horizon Therapeutics Public (HZNP) Ireland $22.481B 28.74
Alnylam Pharmaceuticals (ALNY) United States $21.034B 0.00
Bio-Rad Laboratories (BIO.B) United States $20.768B 44.27
Bio-Techne Corp (TECH) United States $18.755B 98.62
Exact Sciences (EXAS) United States $18.543B 0.00
Incyte (INCY) United States $17.011B 33.63
ARGENX SE-ADR (ARGX) Netherlands $15.660B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $15.484B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.022B 100.96
Zai Lab (ZLAB) China $13.725B 0.00
Repligen (RGEN) United States $13.490B 102.80
Novavax (NVAX) United States $13.287B 0.00
QIAGEN (QGEN) Netherlands $12.035B 20.38
Guardant Health (GH) United States $11.103B 0.00
Intellia Therapeutics (NTLA) United States $9.668B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $9.222B 23.68
CureVac (CVAC) Germany $9.207B 0.00
Mirati Therapeutics (MRTX) United States $8.233B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $8.200B 0.00
Fate Therapeutics (FATE) United States $7.786B 0.00
Acceleron Pharma (XLRN) United States $7.591B 0.00
Ascendis Pharma (ASND) Denmark $6.362B 0.00
Legend Biotech (LEGN) United States $6.224B 0.00
Denali Therapeutics (DNLI) United States $6.184B 221.87
SWEDISH ORP BIO (BIOVF) Sweden $6.024B 21.59
Twist Bioscience (TWST) United States $6.016B 0.00
I-Mab (IMAB) China $6.009B 0.00
Halozyme Therapeutics (HALO) United States $5.885B 32.29
Beam Therapeutics (BEAM) United States $5.757B 0.00
NeoGenomics (NEO) United States $5.436B 922.00
Sarepta Therapeutics (SRPT) United States $5.407B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.387B 0.00
Exelixis (EXEL) United States $5.281B 84.25
Apellis Pharmaceuticals (APLS) United States $5.151B 0.00
Blueprint Medicines (BPMC) United States $5.147B 14.52
Adaptive Biotechnologies (ADPT) United States $5.144B 0.00
Arvinas (ARVN) United States $4.953B 0.00
Vir Biotechnology (VIR) United States $4.636B 0.00
Reata Pharmaceuticals (RETA) United States $4.546B 0.00
SpringWorks Therapeutics (SWTX) United States $4.205B 0.00
Alkermes (ALKS) Ireland $4.174B 123.19
Certara (CERT) United States $4.163B 0.00
AbCellera Biologics (ABCL) $4.110B 0.00
Galapagos (GLPG) Belgium $3.967B 0.00
Arena Pharmaceuticals (ARNA) United States $3.755B 0.00
Emergent Biosolutions (EBS) United States $3.531B 8.54
ACADIA Pharmaceuticals (ACAD) United States $3.465B 0.00
Berkeley Lights (BLI) United States $3.041B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.885B 0.00
Editas Medicine (EDIT) United States $2.839B 0.00
Intra-Cellular Therapies (ITCI) United States $2.788B 0.00
Kymera Therapeutics (KYMR) United States $2.710B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.653B 0.00
Insmed (INSM) United States $2.546B 0.00
Heska (HSKA) United States $2.509B 1094.09
Amicus Therapeutics (FOLD) United States $2.472B 0.00
Vericel (VCEL) United States $2.454B 661.75
Sorrento Therapeutics (SRNE) United States $2.443B 0.00
Myriad Genetics (MYGN) United States $2.437B 0.00
ALX Oncology Holdings (ALXO) United States $2.356B 0.00
Arcus Biosciences (RCUS) United States $2.230B 0.00
Prothena (PRTA) Ireland $2.213B 0.00
Protagonist Therapeutics (PTGX) United States $2.172B 0.00
Cytokinetics (CYTK) United States $2.129B 0.00
Morphic Holding (MORF) United States $2.087B 0.00
Revance Therapeutics (RVNC) United States $2.080B 0.00
Atea Pharmaceuticals (AVIR) United States $2.072B 0.00
Celldex Therapeutics (CLDX) United States $2.033B 0.00
Seer (SEER) $1.959B 0.00
Instil Bio (TIL) United States $1.938B 0.00
Alector (ALEC) United States $1.917B 0.00
Ligand Pharmaceuticals (LGND) United States $1.890B 27.68
Myovant Sciences (MYOV) United Kingdom $1.889B 0.00
C4 Therapeutics (CCCC) United States $1.863B 0.00
MorphoSys AG (MOR) Germany $1.830B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.767B 0.00
Inovio Pharmaceuticals (INO) United States $1.759B 0.00
Castle Biosciences (CSTL) United States $1.750B 0.00
Bluebird Bio (BLUE) United States $1.714B 0.00
Global Blood Therapeutics (GBT) United States $1.702B 0.00
Bionano Genomics (BNGO) United States $1.654B 0.00
Amarin (AMRN) Ireland $1.634B 0.00
PHARMA MAR SA (PHMMF) Spain $1.576B 0.00
NGM Biopharmaceuticals (NGM) United States $1.570B 0.00
Avid Bioservices (CDMO) United States $1.567B 641.25
Harmony Biosciences Holdings (HRMY) United States $1.489B 0.00
Zymeworks (ZYME) Canada $1.482B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.449B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.442B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.440B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.411B 0.00
BioAtla (BCAB) United States $1.380B 0.00
Sangamo Therapeutics (SGMO) United States $1.378B 0.00
REGENXBIO (RGNX) United States $1.374B 0.00
MiMedx (MDXG) United States $1.372B 0.00
PureTech Health (PRTC) United States $1.366B 0.00
Nurix Therapeutics (NRIX) United States $1.366B 0.00
Codexis (CDXS) United States $1.365B 0.00
UniQure (QURE) Netherlands $1.337B 4.55
Ocugen (OCGN) United States $1.330B 0.00
Zealand Pharma (ZEAL) Denmark $1.328B 0.00
Genetron Holdings (GTH) China $1.262B 0.00
Repare Therapeutics (RPTX) Canada $1.236B 0.00
Agenus (AGEN) United States $1.152B 0.00
Precigen (PGEN) United States $1.133B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.084B 0.00
Inhibrx (INBX) United States $1.076B 0.00
Scholar Rock Holding (SRRK) United States $1.075B 0.00
Dynavax Technologies (DVAX) United States $1.070B 0.00
Northwest Biotherapeutics (NWBO) United States $1.045B 0.00
Nkarta (NKTX) United States $1.042B 0.00
Zealand Pharma (ZLDPF) Denmark $1.035B 0.00
MannKind (MNKD) United States $1.022B 0.00
Coherus BioSciences (CHRS) United States $0.989B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.952B 0.00
Shattuck Labs (STTK) United States $0.924B 0.00
Mesoblast (MESO) Australia $0.908B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.907B 28.12
Keros Therapeutics (KROS) United States $0.857B 0.00
Travere Therapeutics (TVTX) United States $0.831B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.824B 0.00
Prometheus Biosciences (RXDX) United States $0.815B 0.00
IDEAYA Biosciences (IDYA) United States $0.806B 0.00
Sutro Biopharma (STRO) United States $0.785B 0.00
RAPT THERAPTICS (RAPT) United States $0.767B 0.00
Mersana Therapeutics (MRSN) United States $0.765B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.761B 0.00
VBI Vaccines (VBIV) United States $0.758B 0.00
G1 THERAPEUTICS (GTHX) United States $0.728B 0.00
Pharming Group (PHAR) Netherlands $0.727B 0.00
Avidity Biosciences (RNA) United States $0.726B 0.00
Pliant Therapeutics (PLRX) United States $0.725B 0.00
Pharming Group (PHGUF) Netherlands $0.720B 23.00
Xenon Pharmaceuticals (XENE) Canada $0.708B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.703B 0.00
Curis (CRIS) United States $0.695B 0.00
Epizyme (EPZM) United States $0.676B 0.00
Adagene (ADAG) China $0.673B 0.00
Merus (MRUS) Netherlands $0.660B 0.00
Affimed (AFMD) Germany $0.654B 0.00
Seres Therapeutics (MCRB) United States $0.651B 0.00
Kadmon Holdings (KDMN) United States $0.647B 0.00
SESEN BIO, INC (SESN) United States $0.646B 0.00
Akoya Biosciences (AKYA) United States $0.644B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
AnaptysBio (ANAB) United States $0.629B 0.00
MeiraGTx Holdings (MGTX) United States $0.620B 0.00
Cara Therapeutics (CARA) United States $0.599B 52.04
ChromaDex (CDXC) United States $0.590B 0.00
Cellectis S.A (CLLS) France $0.589B 0.00
Anika Therapeutics (ANIK) United States $0.578B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.574B 0.00
DBV Technologies S.A (DBVT) France $0.572B 0.00
Precision BioSciences (DTIL) United States $0.567B 0.00
Verastem (VSTM) United States $0.555B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.555B 0.00
ALBIREO PHARMA (ALBO) United States $0.549B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.544B 0.00
AC Immune SA (ACIU) Switzerland $0.529B 0.00
Clene (CLNN) United States $0.528B 0.00
Inventiva S.A (IVA) France $0.519B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.511B 9.32
VistaGen Therapeutics (VTGN) United States $0.511B 0.00
Clovis Oncology (CLVS) United States $0.505B 0.00
Vaccitech (VACC) United Kingdom $0.500B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.489B 0.00
XBiotech (XBIT) United States $0.486B 0.00
Compugen (CGEN) Israel $0.465B 0.00
Cybin (CLXPF) Canada $0.454B 0.00
ANI Pharmaceuticals (ANIP) United States $0.420B 11.58
Kindred Biosciences (KIN) United States $0.415B 0.00
Starpharma Holdings (SPHRY) Australia $0.413B 0.00
Athenex (ATNX) United States $0.412B 0.00
Bolt Biotherapeutics (BOLT) United States $0.405B 0.00
Forte Biosciences (FBRX) United States $0.405B 0.00
Spero Therapeutics (SPRO) United States $0.396B 0.00
Oncobiologics (OTLK) United States $0.392B 0.00
Selecta Biosciences (SELB) United States $0.392B 0.00
Geron (GERN) United States $0.389B 0.00
Codiak BioSciences (CDAK) United States $0.381B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.375B 0.00
BeyondSpring (BYSI) United States $0.372B 0.00
BioDelivery Sciences (BDSI) United States $0.370B 15.04
Amryt Pharma (AMYT) United Kingdom $0.370B 0.00
Athersys (ATHX) United States $0.369B 0.00
XOMA (XOMA) United States $0.365B 170.53
Orchard Therapeutics (ORTX) United Kingdom $0.355B 0.00
CytomX Therapeutics (CTMX) United States $0.352B 0.00
AquaBounty Technologies (AQB) United States $0.352B 0.00
SQZ Biotechnologies (SQZ) United States $0.337B 0.00
Gritstone Bio (GRTS) United States $0.329B 0.00
Theratechnologies (THTX) Canada $0.328B 0.00
Cue Biopharma (CUE) United States $0.327B 0.00
UROGEN PHARMA (URGN) United States $0.324B 0.00
Angion Biomedica (ANGN) United States $0.315B 0.00
Puma Biotechnology (PBYI) United States $0.304B 0.00
Fortress Biotech (FBIO) United States $0.303B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.301B 0.00
Neoleukin Therapeutics (NLTX) United States $0.296B 0.00
Opthea (OPT) Australia $0.289B 0.00
Syros Pharmaceuticals (SYRS) United States $0.286B 0.00
Frequency Therapeutics (FREQ) United States $0.285B 0.00
Clearside Biomedical (CLSD) United States $0.283B 0.00
WAVE Life Sciences (WVE) Singapore $0.277B 0.00
Talis Biomedical (TLIS) United States $0.264B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.263B 0.00
Innate Pharma S.A (IPHA) France $0.262B 0.00
Prima BioMed (IMMP) Australia $0.261B 0.00
Arbutus Biopharma (ABUS) United States $0.259B 0.00
Cerecor (CERC) United States $0.254B 0.00
OVID THERAPEUTC (OVID) United States $0.253B 2.49
Paratek Pharmaceuticals (PRTK) United States $0.244B 0.00
Kamada (KMDA) Israel $0.242B 16.49
INmune Bio (INMB) United States $0.241B 0.00
Fulcrum Therapeutics (FULC) United States $0.239B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.236B 0.00
Adicet Bio (ACET) United States $0.235B 0.00
Chiasma (CHMA) United States $0.232B 0.00
Kaleido Biosciences (KLDO) $0.231B 0.00
Cogent Biosciences (COGT) United States $0.230B 0.00
Bellus Health (BLU) Canada $0.227B 0.00
Kala Pharmaceuticals (KALA) United States $0.223B 0.00
Adverum Biotechnologies (ADVM) United States $0.222B 0.00
CorMedix Inc (CRMD) United States $0.221B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.220B 0.00
Trevena (TRVN) United States $0.219B 0.00
TELA Bio (TELA) United States $0.217B 0.00
OSMOTICA PHARM (OSMT) United States $0.208B 0.00
Checkpoint Therapeutics (CKPT) United States $0.208B 0.00
HOOKIPA Pharma (HOOK) United States $0.201B 0.00
Cardiff Oncology (CRDF) United States $0.200B 0.00
ADMA Biologics Inc (ADMA) United States $0.199B 0.00
NextCure (NXTC) United States $0.191B 0.00
Beyond Air (XAIR) United States $0.183B 0.00
Seelos Therapeutics (SEEL) United States $0.177B 0.00
Biofrontera AG (BFRA) Germany $0.172B 0.00
GENFIT S.A (GNFT) France $0.171B 0.00
Aptinyx (APTX) United States $0.171B 0.00
Nicox SA (NICXF) France $0.171B 0.00
POXEL SA FRANCE (PXXLF) France $0.170B 0.00
Erytech Pharma SA (ERYP) France $0.168B 0.00
Synlogic (SYBX) United States $0.166B 0.00
Strongbridge Biopharma (SBBP) United States $0.162B 0.00
PHASEBIO PHARMA (PHAS) United States $0.160B 0.00
Enzo Biochem (ENZ) United States $0.158B 46.57
VTv Therapeutics (VTVT) United States $0.156B 0.00
Applied Genetic Technologies (AGTC) United States $0.154B 0.00
ObsEva SA (OBSV) Switzerland $0.145B 0.00
Purple Biotech (PPBT) Israel $0.143B 0.00
X4 Pharmaceuticals (XFOR) United States $0.142B 0.00
Antibe Therapeutics (ATBPF) Canada $0.139B 0.00
LogicBio Therapeutics (LOGC) United States $0.134B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.132B 0.00
ABVC BioPharma (ABVC) United States $0.132B 0.00
Viridian Therapeutics (VRDN) United States $0.131B 0.00
Galena Biopharma (SLS) United States $0.129B 0.00
Catalyst Biosciences (CBIO) United States $0.128B 0.00
Eton Pharmaceuticals (ETON) United States $0.126B 0.00
Cyclerion Therapeutics (CYCN) United States $0.126B 0.00
Abeona Therapeutics (ABEO) United States $0.124B 0.00
Entera Bio (ENTX) Israel $0.122B 0.00
Orgenesis (ORGS) United States $0.120B 0.00
Liquidia Technologies (LQDA) United States $0.120B 0.00
Voyager Therapeutics (VYGR) United States $0.119B 3.06
Exicure (XCUR) United States $0.119B 0.00
Novogen (KZIA) Australia $0.117B 0.00
Cocrystal Pharma (COCP) United States $0.113B 0.00
Eyenovia (EYEN) United States $0.109B 0.00
Longeveron (LGVN) United States $0.109B 0.00
Dyadic (DYAI) United States $0.107B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.105B 0.00
Vascular Biogenics (VBLT) Israel $0.105B 0.00
Pluristem Therapeutics (PSTI) Israel $0.104B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.101B 0.00
Aytu BioPharma (AYTU) United States $0.100B 0.00
Celsion (CLSN) United States $0.096B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.096B 0.00
Yumanity Therapeutics (YMTX) United States $0.093B 0.00
AEterna Zentaris (AEZS) United States $0.088B 0.00
Evofem Biosciences (EVFM) United States $0.088B 0.00
Liminal BioSciences (LMNL) Canada $0.088B 0.00
ARAVIVE, INC (ARAV) United States $0.086B 0.00
Vyant Bio (VYNT) United States $0.086B 0.00
Leap Therapeutics (LPTX) United States $0.085B 0.00
Aptevo Therapeutics (APVO) United States $0.084B 0.00
Zosano Pharma (ZSAN) United States $0.081B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.079B 0.00
AIkido Pharma (AIKI) United States $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
ATyr Pharma (LIFE) United States $0.075B 0.00
Emmaus Life Sciences (EMMA) United States $0.074B 0.00
Evogene (EVGN) Israel $0.074B 0.00
Cidara Therapeutics (CDTX) United States $0.073B 0.00
Vaccinex (VCNX) United States $0.070B 0.00
Cytocom (CBLI) United States $0.067B 0.00
Edesa Biotech (EDSA) Canada $0.066B 0.00
Celyad SA (CYAD) Belgium $0.066B 0.00
DiaMedica Therapeutics (DMAC) United States $0.065B 0.00
Lumos Pharma (LUMO) United States $0.063B 0.00
Alimera Sciences (ALIM) United States $0.061B 0.00
Advaxis (ADXS) United States $0.060B 0.00
TRACON Pharmaceuticals (TCON) United States $0.058B 0.00
Oncotelic Therapeutics (OTLC) United States $0.057B 0.00
ARIDIS PHARMACT (ARDS) United States $0.056B 0.00
BioCardia (BCDA) United States $0.056B 0.00
Organovo Holdings (ONVO) United States $0.055B 0.00
Cyclo Therapeutics (CYTH) United States $0.053B 0.00
Genetic Technologies (GENE) Australia $0.052B 0.00
Idera Pharmaceuticals (IDRA) United States $0.052B 0.00
Windtree Therapeutics (WINT) United States $0.050B 0.00
Pulmatrix (PULM) United States $0.048B 0.00
AnPac Bio-Medical Science (ANPC) China $0.047B 0.00
Happiness Biotech Group (HAPP) China $0.046B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.046B 0.00
Invo BioScience (INVO) United States $0.045B 0.00
Enveric Biosciences (ENVB) United States $0.041B 0.00
Soligenix (SNGX) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.86
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
Vallon Pharmaceuticals (VLON) United States $0.031B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
GeoVax Labs (GOVX) United States $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
ThermoGenesis Holdings (THMO) United States $0.028B 0.00
Benitec Biopharma (BNTC) United States $0.027B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.022B 0.00
ZIVO Bioscience (ZIVO) United States $0.019B 0.00
Palisade Bio (PALI) United States $0.008B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00